Axsome Presents Secondary Endpoints for Solriamfetol in SHARP Study
Solriamfetol is being trialed in 59 patients with excessive daytime sleepiness associated with obstructive sleep apnea and impaired cognitive function.
Read MoreSolriamfetol is being trialed in 59 patients with excessive daytime sleepiness associated with obstructive sleep apnea and impaired cognitive function.
Read MoreScientists have discovered how elephant seals manage to get some shut-eye during their extended months-long foraging trips at sea.
Read MoreAt night, the sleep laboratory will focus on overnight testing and diagnostics for children who may have sleep disorders, including sleep apnea, narcolepsy, or pediatric limb movement disorder.
Read MoreSleep specialist William H. Noah, MD, is challenging industry norms by sharing case reports on his experiments with a CPAP mask algorithm adjustment.
Read MoreEmpatica Actigraphy was developed to suit the needs of sleep and activity-related studies and provide digital biomarkers across various core areas.
Read More